Brimonidine Tartrate; Timolol Maleate Patent Expiration
Brimonidine Tartrate; Timolol Maleate is used for lowering elevated intraocular pressure in patients with glaucoma or ocular hypertension. It was first introduced by Abbvie Inc
Brimonidine Tartrate; Timolol Maleate Patents
Given below is the list of patents protecting Brimonidine Tartrate; Timolol Maleate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Combigan | US7323463 | Combination of brimonidine and timolol for topical ophthalmic use |
Jan 19, 2023
(Expired) | Abbvie |
| Combigan | US7030149 | Combination of brimonidine timolol for topical ophthalmic use |
Apr 19, 2022
(Expired) | Abbvie |
| Combigan | US7320976 | Combination of brimonidine and timolol for topical ophthalmic use |
Apr 19, 2022
(Expired) | Abbvie |
| Combigan | US7642258 | Combination of brimonidine and timolol for topical ophthalmic use |
Apr 19, 2022
(Expired) | Abbvie |
| Combigan | US8133890 | Combination of brimonidine and timolol for topical ophthalmic use |
Apr 19, 2022
(Expired) | Abbvie |
| Combigan | US8354409 | Combination of brimonidine and timolol for topical ophthalmic use |
Apr 19, 2022
(Expired) | Abbvie |
| Combigan | US8748425 | Combination of brimonidine and timolol for topical ophthalmic use |
Apr 19, 2022
(Expired) | Abbvie |
| Combigan | US9474751 | Combination of brimonidine and timolol for topical ophthalmic use |
Apr 19, 2022
(Expired) | Abbvie |
| Combigan | US9770453 | Combination of brimonidine and timolol for topical ophthalmic use |
Apr 19, 2022
(Expired) | Abbvie |
| Combigan | US9907801 | Combination of brimonidine and timolol for topical ophthalmic use |
Apr 19, 2022
(Expired) | Abbvie |
| Combigan | US9907802 | Combination of brimonidine and timolol for topical ophthalmic use |
Apr 19, 2022
(Expired) | Abbvie |
Brimonidine Tartrate; Timolol Maleate's Family Patents
Explore Our Curated Drug Screens
Brimonidine Tartrate; Timolol Maleate Generics
Several generic applications have been filed for Brimonidine Tartrate; Timolol Maleate. The first generic version for Brimonidine Tartrate; Timolol Maleate was by Sandoz Inc and was approved on Apr 4, 2022. And the latest generic version is by Somerset Therapeutics Llc and was approved on Sep 10, 2024.
Given below is the list of companies who have filed for Brimonidine Tartrate; Timolol Maleate generic.
1. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 1 generic for Brimonidine Tartrate; Timolol Maleate. This 0.2%;eq 0.5% base version comes by the name BRIMONIDINE TARTRATE AND TIMOLOL MALEATE. Given below are the details of the strengths of this generic introduced by Alembic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.2%; EQ 0.5% BASE | solution/drops | Prescription | OPHTHALMIC | AB | Aug 25, 2023 |
2. APOTEX
Apotex Inc has filed for 1 generic for Brimonidine Tartrate; Timolol Maleate. This 0.2%;eq 0.5% base version comes by the name BRIMONIDINE TARTRATE AND TIMOLOL MALEATE. Given below are the details of the strengths of this generic introduced by Apotex.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.2%; EQ 0.5% BASE | solution/drops | Prescription | OPHTHALMIC | AB | Apr 20, 2022 |
3. FLORIDA
Florida Pharmaceutical Products Llc has filed for 1 generic for Brimonidine Tartrate; Timolol Maleate. This 0.2%;eq 0.5% base version comes by the name BRIMONIDINE TARTRATE AND TIMOLOL MALEATE. Given below are the details of the strengths of this generic introduced by Florida.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.2%; EQ 0.5% BASE | solution/drops | Prescription | OPHTHALMIC | AB | Oct 4, 2022 |
4. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 1 generic for Brimonidine Tartrate; Timolol Maleate. This 0.2%;eq 0.5% base version comes by the name BRIMONIDINE TARTRATE AND TIMOLOL MALEATE. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.2%; EQ 0.5% BASE | solution/drops | Prescription | OPHTHALMIC | AB | May 16, 2024 |
5. SANDOZ
Sandoz Inc has filed for 1 generic for Brimonidine Tartrate; Timolol Maleate. This 0.2%;eq 0.5% base version comes by the name BRIMONIDINE TARTRATE AND TIMOLOL MALEATE. Given below are the details of the strengths of this generic introduced by Sandoz.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.2%; EQ 0.5% BASE | solution/drops | Prescription | OPHTHALMIC | AB | Apr 4, 2022 |
6. SENTISS
Sentiss Ag has filed for 1 generic for Brimonidine Tartrate; Timolol Maleate. This 0.2%;eq 0.5% base version comes by the name BRIMONIDINE TARTRATE AND TIMOLOL MALEATE. Given below are the details of the strengths of this generic introduced by Sentiss.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.2%; EQ 0.5% BASE | solution/drops | Prescription | OPHTHALMIC | AB | Oct 31, 2022 |
7. SOMERSET
Somerset Therapeutics Llc has filed for 1 generic for Brimonidine Tartrate; Timolol Maleate. This 0.2%;eq 0.5% base version comes by the name BRIMONIDINE TARTRATE AND TIMOLOL MALEATE. Given below are the details of the strengths of this generic introduced by Somerset.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.2%; EQ 0.5% BASE | solution/drops | Prescription | OPHTHALMIC | AB | Sep 10, 2024 |
8. UPSHER SMITH LABS
Upsher Smith Laboratories Llc has filed for 1 generic for Brimonidine Tartrate; Timolol Maleate. This 0.2%;eq 0.5% base version comes by the name BRIMONIDINE TARTRATE AND TIMOLOL MALEATE. Given below are the details of the strengths of this generic introduced by Upsher Smith Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.2%; EQ 0.5% BASE | solution/drops | Prescription | OPHTHALMIC | AB | Dec 12, 2022 |